Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Simplification

I posted my concerns several years ago about a joint venture between a public and private company and how it could affect certain disclosure requirements. I brought it up again when in the J's decision the settlement was not disclosed in the 8K as a "material event".(which by the way I never was given a response to my e-mail with that concern) TPL may be handling all the litigation in our joint venture, but that doesn't preclude them from allowing PTSC or PTSC demanding that certain disclosures are made to investors. It even states in the master agreement that TPL will be allowed to monitor all news releases except that information which is required by the SEC. I think they are backsliding. My only concern is with information that we still do not know about. What else could the be hiding? The NDA would be a good example.

There is the posibility that that the German events, whatever they were that lead to the re-exam, were started before our joint venture. Are they required to report information retroactive to our agreement, anf if so what else do we not know?

Share
New Message
Please login to post a reply